Lightnews — Scholar-powered news

HematoRules @hematorules.bsky.social · 1d

@drmiguelperales.bsky.social at #Hemato2025

VII Conferencia Ciril Rozman

2 2

HematoRules @hematorules.bsky.social · Apr 11

#LymphoidWorld
AgoraH Reunion hoy en Madrid!

@sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!

2

HematoRules @hematorules.bsky.social · Apr 10

Piropos de verdad! Comentarios que alegran el día y dan sentido al #HematoWorld!

Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados!

5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social

Si aún tienes dudas… mis DM están disponibles 24/7

1

HematoRules @hematorules.bsky.social · Apr 3

New comment on @bloodjournal.bsky.social of our #ICOnic @albertomussetti.bsky.social & @annasureda.bsky.social about Prizloncabtagene autoleucel: New #CART for cell B #Lymphoma!

Available here
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
ashpublications.org/blood/articl...

Prizloncabtagene autoleucel: a new CAR T cell for B-NHL

In this issue of Blood, Yu et al reported promising clinical results of prizloncabtagene autoleucel (prizlon-cel), a next-generation chimeric antigen recep

ashpublications.org

1 2

HematoRules @hematorules.bsky.social · Apr 3

🚨 NEW #ICOnic PUBLICATION 🚨
Congratulations @martape28.bsky.social et al. For this paper!

Now available online
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
www.nature.com/articles/s41...

Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC - Bone Marrow Transp...

Bone Marrow Transplantation - Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on...

www.nature.com

2 1

HematoRules @hematorules.bsky.social · Apr 3

What a great meeting #EBMT25 with a great and #ICOnic participation of Institut Català d’Oncología

Until the next one! See you in Madrid #EBMT26

1

Reposted by HematoRules

Alberto Mussetti @albertomussetti.bsky.social · Apr 1

Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee

authors.elsevier.com/a/1ks1w5EIIg...

authors.elsevier.com

2 2

Reposted by HematoRules

American Society of Hematology @ash.hematology.org · Mar 27

🚨 New Research Alert! 🚨 A machine learning tool is aiding patients with #myelofibrosis and doctors in making better #transplant decisions! Developed by The EBMT, it outperforms traditional methods. Read more in the press release: www.hematology.org/n...

#Hematology #HemeOnc #HemeSky #MedSky

1 3 8

Reposted by HematoRules

Ajay Major, MD, MBA @majorajay.bsky.social · Mar 27

Patients with Hodgkin lymphoma refractory/intolerant to both BV & checkpoint inhibitors (an increasing reality in the modern era) have median OS 7.4 yrs. This is a new benchmark in novel trials for R/R cHL. Thank you for the opportunity to participate! #lymsm #medsky
www.nature.com/articles/s41...

1 5

Reposted by HematoRules

Raffaella Greco @raffaellagreco.bsky.social · Feb 6

Post-transplant cyclophosphamide in matched donor transplantation, current state of the art 📌
www.sciencedirect.com/science/arti...

Post-transplant cyclophosphamide in matched donor transplantation: are we there yet?

Graft-versus-host disease (GvHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (alloHCT) and…

www.sciencedirect.com

1 4

Reposted by HematoRules

Julia Maxson @juliamaxson.bsky.social · Feb 6

I feel like we could all use something fun to look forward to right about now!!! 🧪🧪🧪

Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT!

events.faseb.org/event/hemato...

Flyer for FASEB hematologic malignancies meeting. July 27-31 2025. Southbridge Massachusetts. Keynote speakers: Jennifer Trowbridge and George Vassilou

8 8

HematoRules @hematorules.bsky.social · Dec 24

🎄Merry Xmas🎄
#HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you!

I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this!

We won’t stop until We’ve beaten Blood Cancer! 💪🏼

Reposted by HematoRules

Miguel Perales MD @drmiguelperales.bsky.social · Dec 10

If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW

14 29

Reposted by HematoRules

Ajay Major, MD, MBA @majorajay.bsky.social · Dec 8

#ASH24 plenary: ketogenic diet & CAR-T efficacy
- ketogenic diet➡️cytokine release & CAR expansion in mouse xenograft via beta-hydroxybutyrate
- in pts, BHB correlates w/ CAR expansion and giving BHB to 3 pts enhanced T-cell oxphos
Fascinating! BHB + CAR-T trial is open. #tcellrx

3 11

Reposted by HematoRules

Nihar Desai MD, DM @nihardesai7.bsky.social · Dec 3

The slide set is almost ready!!

I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼

See you all soon 😍

#MedSky

1 14

Reposted by HematoRules

Bruce Levine, Ph.D. 🇺🇦 @bllphd.bsky.social · Dec 5

#ASH24 Energy matters! Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate #CARTCell #TCell #tcellrx #immunotherapy @PennMedicine
ash.confex.com/ash/2024/web...

a close up of a woman 's face with a surprised look on her face .

ALT: a close up of a woman 's face with a surprised look on her face .

media.tenor.com

1 5 8

Reposted by HematoRules

American Society of Hematology @ash.hematology.org · Dec 4

Four haikus, one post,
A cascade of thought and art—
ASH voices converge.

Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!

Stephanie Xie @stephxie.bsky.social · Dec 4

#ASH24 like no other in 4 #ASHaiku

This is the big time,
Scientific committee,
Three ASH abstracts. Slay!!!

Anticipating
amazing 501 talks.
Moderating too!

Saturday oral,
New human HSC state.
I’m one proud mentor.

Thrilled for first meeting,
Stem cells and regenerative
medicine. Honored!
👇

1 2 19

Reposted by HematoRules

Ajay Major, MD, MBA @majorajay.bsky.social · Dec 3

17. #MajorPROsASH: Lactuamab CTCL PROs #lymsm
- SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45
- MF: PRO improvements occurred later (weeks 29-37)
Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24

1 1

Reposted by HematoRules

Ajay Major, MD, MBA @majorajay.bsky.social · Dec 3

16. #MajorPROsASH: STARGLO RCT PROs #lymsm #ASH24
- clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5)
- median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi?
- EOT: sustained improvements in pain & lymphoma sx both arms

1 1

Reposted by HematoRules

Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · Dec 3

🌟 ABX Pearl of the Day: ESBL cystitis

💡 Q: Can I use amoxicillin/clavulanate to treat ESBL E. coli cystitis if the micro reports it being susceptible?
#IDsky #MedSky #PharmSky #SkyRX #AMSsky

1 6 18

Reposted by HematoRules

American Society of Hematology @ash.hematology.org · Dec 3

Please join us in welcoming the incoming 2025 ASH President @b-avalos-md.bsky.social to our thriving Bluesky community! #HemeSky #Hematology #ASH24 🎉

Belinda Avalos, MD @b-avalos-md.bsky.social · Dec 3

#ASHThrowback to the #ASH16 MMSAP (now HIP) reception, which I am looking forward to attending again at #ASH24. I am also looking forward to receiving the gavel as the incoming
@ash-hematology.bsky.social 2025 president and sharing my experience here! #HemeSky #hematology

2 5 21

Reposted by HematoRules

Ajay Major, MD, MBA @majorajay.bsky.social · Dec 3

20. #MajorPROsASH: CLL13 PROs #leusm
- RV/GV: global QOL w/ sustained improvement
- GIV: QOL did not improve during tx!
- median time to improvement fatigue: ~5 mos in RV/GV/GIV arms
- diarrhea worse with GIV vs all other arms
Worse sx burden with GIV! Stick with GV. #ASH24

1 1

Reposted by HematoRules

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · Dec 3

Applications for MSK's QSURE 2025 summer #internship program are now open! This program provides undergraduate students hands-on experience in quantitative science research. Applications are due by 5pm ET on 1/18. Apply ⬇️ www.mskcc.org/departments/...

3 7

Reposted by HematoRules

Alisa Wolberg, PhD @aswolberg.bsky.social · Dec 3

If you haven’t seen it yet, the #ASH24 app allows us to search by disease. I see lots of #hemostasis and #thrombosis to choose from, as well as tons of other other cool science. #hemesky is bright!

American Society of Hematology @ash.hematology.org · Dec 3

Now is the perfect time to download the #ASH24 app! Plan your schedule in advance and access the complete program, full text of all abstracts, maps of the convention center, and much more.

iOS: ow.ly/NQbs50UjV4v
Android: ow.ly/45Zr50UjV4w

#HemeSky #BloodSky #MedSky #Hematology

2 7

Reposted by HematoRules

American Society of Hematology @ash.hematology.org · Dec 3

📹 Make the most of the ASH Annual Meeting — here's what you need to know before you go!

www.youtube.com/watch?v=QGDX...

Learn about registration hours and locations, download the
#ASH24 app, & preview the virtual platform and the new food guide! 😋🍔Check your email.

#HemeSky #Hematology

Know Before You Go: 66th ASH Annual Meeting and Exposition

YouTube video by American Society of Hematology

www.youtube.com

1 7 22